In a significant development at the 2026 edition of the Officine Expo in Marrakech, Sothema and the Naali brand have inked a memorandum of understanding, marking a strategic partnership for the marketing of Naali products by the Moroccan pharmaceutical giant.
This collaboration is set to capitalize on Sothema's industrial prowess and regional footprint to foster the advancement of innovative solutions derived from saffron research. Established in 2020, Naali has carved out a niche in the dietary supplement market with a product line enriched with saffron, specifically aimed at enhancing mental health and women's well-being.
By integrating these products into its portfolio, Sothema reinforces its strategy of therapeutic diversification, emphasizing innovation, scientific rigor, and broadening its scope of intervention. This agreement also paves the way for new growth avenues for Naali, which will gain from a well-structured distribution network both in Morocco and on the international stage.
Naali is a brand dedicated to dietary supplements that promote emotional balance for the entire family. Its methodology hinges on a specialized saffron extraction process, enabling precise control over its primary active compounds, particularly safranal and crocin, to provide targeted and accessible solutions for all ages, from children to adults.
Founded in 1976, Sothema is a leader in the production and distribution of pharmaceuticals, dietary supplements, and medical devices. The group operates across Morocco, sub-Saharan Africa, and the Middle East, offering licensed products developed in partnership with approximately forty international laboratories, alongside its own generics and biosimilars.


chargement...





